Asterias Biotherapeutics AST MY Big Board Pick
Post# of 97986
Posted On: 03/01/2015 1:45:53 PM
Asterias Biotherapeutics AST
MY Big Board Pick !!! AST NYSE
This small cap biotech outfit sells itself as being in regenerative medicine with a stem cell technology platform. The boutique firm MLV started coverage with a Buy rating. What stands out here is that the $9 price target would imply a potential upside return of over 125% from Friday’s closing price of $3.98 and the pre-call close of $3.95.
Asterias Biotherapeutics Inc. (NYSEMKT: AST) has a mere $123 million market cap. It has a 52-week range of $1.51 to $6.95, and it recently raised about $5.5 million via a public offering. Be advised that this small player just moved from the OTC Bulletin Board last October to the NYSE MKT.
Two disclosures about this big rating — first is that MLV served as sole book-running manager for the recent capital raise, and second is that the average volume is under 50,000 shares per day and that it has only traded over 100,000 shares twice so far in 2015.
247wallst.cominvesting/2015/02/28/5-small-cap-analyst-stocks-under-10-with-massive-upside-potential
http://finance.yahoo.com/q?s=AST&ql=0
finance.yahoo.com/q?s=AST&ql=0
MY Big Board Pick !!! AST NYSE
This small cap biotech outfit sells itself as being in regenerative medicine with a stem cell technology platform. The boutique firm MLV started coverage with a Buy rating. What stands out here is that the $9 price target would imply a potential upside return of over 125% from Friday’s closing price of $3.98 and the pre-call close of $3.95.
Asterias Biotherapeutics Inc. (NYSEMKT: AST) has a mere $123 million market cap. It has a 52-week range of $1.51 to $6.95, and it recently raised about $5.5 million via a public offering. Be advised that this small player just moved from the OTC Bulletin Board last October to the NYSE MKT.
Two disclosures about this big rating — first is that MLV served as sole book-running manager for the recent capital raise, and second is that the average volume is under 50,000 shares per day and that it has only traded over 100,000 shares twice so far in 2015.
247wallst.cominvesting/2015/02/28/5-small-cap-analyst-stocks-under-10-with-massive-upside-potential
http://finance.yahoo.com/q?s=AST&ql=0
finance.yahoo.com/q?s=AST&ql=0
(0)
(0)